What is Gyre Therapeutics, Inc.'s net income?

Gyre Therapeutics, Inc. (GYRE) reported net income of -$9.86M in Q1 2026.

How has Gyre Therapeutics, Inc.'s net income changed year-over-year?

Gyre Therapeutics, Inc.'s net income decreased by 364.0% year-over-year, from $3.73M to -$9.86M.

What is the long-term trend for Gyre Therapeutics, Inc.'s net income?

Over 3 years (2021 to 2024), Gyre Therapeutics, Inc.'s net income has grown at a -41.2% compound annual growth rate (CAGR), from -$87.93M to $17.9M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Gyre Therapeutics, Inc. GYRE Net Income

Net Income at other companies

Eli LillyLLY

$7.4B+168%

Madrigal Pharmaceuticals, Inc.MDGL

-$94.39M-28.9%

Viking TherapeuticsVKTX

-$158.33M-247%

Theravance BiopharmaTBPH

-$4.93M+63.7%

Zevra Therapeutics, Inc.ZVRA

$37.89M+1,323%

LQD

Liquidia CorporationLQDA

$52.86M+238%

Segments

By segment

See full

Gyre-$6M-816%

Gyre Pharmaceuticals-$3.85M-233%

All Other Segments-$6K-100%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s net income?: Gyre Therapeutics, Inc. (GYRE) reported net income of -$9.86M in Q1 2026.
How has Gyre Therapeutics, Inc.'s net income changed year-over-year?: Gyre Therapeutics, Inc.'s net income decreased by 364.0% year-over-year, from $3.73M to -$9.86M.
What is the long-term trend for Gyre Therapeutics, Inc.'s net income?: Over 3 years (2021 to 2024), Gyre Therapeutics, Inc.'s net income has grown at a -41.2% compound annual growth rate (CAGR), from -$87.93M to $17.9M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.